Core Points - NACCO Industries announced a quarterly cash dividend of 25.25 cents per share, payable on December 15, 2025, to stockholders of record as of December 1, 2025 [1] - The company approved a new stock repurchase program allowing for the repurchase of up to $20 million of Class A Common Stock through December 31, 2027, replacing the previous program [2] - The CEO expressed confidence in the company's long-term business prospects and indicated that share repurchases will be balanced with other capital needs [3] Dividend Information - The declared dividend is applicable to both Class A and Class B Common Stock [1] - The payment date is set for December 15, 2025, with a record date of December 1, 2025 [1] Stock Repurchase Program - The new program allows for repurchases of up to $20 million, replacing the previous program that was set to expire on December 31, 2025 [2] - The timing and amount of repurchases will be at the discretion of management, influenced by capital availability and market conditions [3] - The program may be modified or terminated at any time without prior notice and can be executed through various methods, including open-market purchases [3]

Core Insights - Texxon Holding Limited reported strong financial results for the fiscal year ended June 30, 2025, with a strategic shift towards high-growth sectors such as automotive, new energy, and chemicals, leading to an 18.5% increase in overall revenue [2][4]. Financial Performance - Revenue for fiscal year 2025 was $797.15 million, up 18.5% from $672.66 million in fiscal year 2024 [4][5]. - Gross profit was $4.70 million, slightly down from $4.82 million in fiscal year 2024, resulting in a gross profit margin of 0.6%, compared to 0.7% the previous year [5][9]. - The company reported a net loss of $1.45 million for fiscal year 2025, a decline from a net income of $2.51 million in fiscal year 2024 [5][14]. - Basic and diluted losses per share were $0.05 for fiscal year 2025, compared to earnings per share of $0.05 in fiscal year 2024 [15]. Revenue Breakdown - Sales of basic chemicals reached $524.64 million, a modest increase of 1.5% from $517.03 million in fiscal year 2024 [6][11]. - Sales of plastic particles surged to $272.39 million, an increase of 88.5% from $144.50 million in fiscal year 2024, driven by increased sales volume [6][11]. - Other products generated $0.12 million in revenue, a significant decrease from $11.13 million in fiscal year 2024, primarily due to no sales of black metal in fiscal year 2025 [11]. Cost and Expenses - Cost of sales was $792.45 million, up 18.7% from $667.85 million in fiscal year 2024, largely due to increased sales volume of plastic particles [7]. - Operating expenses increased by 27.5% to $5.30 million from $4.16 million in fiscal year 2024 [10]. - Selling expenses rose by 21.2% to $2.41 million, attributed to increased marketing personnel and higher commissions [12]. Cash Flow and Financial Condition - As of June 30, 2025, cash and cash equivalents were $2.52 million, up from $0.27 million the previous year [16]. - Net cash provided by operating activities was $2.32 million, a turnaround from net cash used of $30.80 million in fiscal year 2024 [16]. - Net cash used in investing activities was $42.25 million, compared to $11.02 million in fiscal year 2024 [16]. Recent Developments - On October 23, 2025, the company completed its initial public offering of 1,900,000 ordinary shares at $5.00 per share, raising gross proceeds of $10.93 million [18].

Accessibility StatementSkip Navigation WOOD DALE, Ill., Nov. 18, 2025 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, published its 2025 Sustainability Report today, highlighting the continuation and advancement of the Company's environmental, social, and governance commitments. Continue Reading 21% more press release views with Request a Demo Also from this source AAR included among Forbes' America's Dream Employers 20 ...

Vectra Bank Colorado welcomes Dominic Karaba as its next President & CEO Accessibility StatementSkip Navigation SALT LAKE CITY, Nov. 18, 2025 /PRNewswire/ -- Harris Simmons, Chairman and CEO of Zions Bancorporation, N.A. (NASDAQ: ZION), will make a presentation at the Goldman Sachs 2025 Financial Services Conference on Tuesday, December 9 at 1:40 pm Eastern. An audio webcast of the session may be accessed on the Zions Bancorporation website, zionsbancorporation.com. The webcast will also be archived and av ...

Accessibility StatementSkip Navigation LOS ANGELES, Nov. 18, 2025 /PRNewswire/ -- B. Riley Financial, Inc. (NASDAQ: RILY) ("BRF" or the "Company"), a diversified holding company, today announced the filing of its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2025. Bryant Riley, Chairman and Co-Chief Executive Officer of B. Riley Financial, commented: "Our first quarter 2025 Form 10-Q filing marks an important step towards timely financial reporting and compliance with Nasdaq listi ...

Accessibility StatementSkip Navigation DUBLIN, Nov. 18, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in Citi's 2025 Global Healthcare Conference. Company management will participate in a fireside chat on Tuesday, December 2, 2025, at 6:45 a.m. PST / 9:45 a.m. EST / 2:45 p.m. GMT. SOURCE Jazz Pharmaceuticals plc 21% more press release views with Request a Demo Also from this source Positive HERIZON-GEA-01 Phase 3 Results Support Ziihera® (zan ...

Core Insights - Dolby Laboratories reported strong financial results for Q4 and fiscal year 2025, highlighting growth in Dolby Atmos, Dolby Vision, and imaging patents, along with an expanded addressable market [1][7]. Financial Highlights - Total revenue for Q4 2025 was $307 million, a slight increase from $305 million in Q4 2024 [7]. - GAAP net income for Q4 2025 was $49 million, or $0.51 per diluted share, compared to $59 million, or $0.61 per diluted share in Q4 2024 [7]. - Non-GAAP net income for Q4 2025 was $96 million, or $0.99 per diluted share, up from $78 million, or $0.81 per diluted share in Q4 2024 [7]. - Full year revenue for fiscal 2025 reached $1.35 billion, compared to $1.27 billion in fiscal 2024 [7]. - GAAP net income for the full year was $255 million, or $2.62 per diluted share, down from $262 million, or $2.69 per diluted share in fiscal 2024 [7]. - Non-GAAP net income for the full year was $414 million, or $4.24 per diluted share, compared to $369 million, or $3.79 per diluted share in fiscal 2024 [7]. Business Developments - Dolby announced a cash dividend of $0.36 per share, payable on December 10, 2025 [4]. - The company repurchased approximately 479,000 shares for about $35 million, with $277 million remaining in stock repurchase authorization [7]. - Dolby Vision 2 was introduced, enhancing the capabilities of modern displays and providing new tools for artists [7]. - Partnerships were established with automakers in India, China, and Vietnam, and new products featuring Dolby technologies were launched by major brands [7]. Financial Outlook - For Q1 2026, total revenue is estimated to range from $315 million to $345 million, with licensing revenue expected between $290 million and $320 million [8]. - Full year 2026 revenue is projected to be between $1.39 billion and $1.44 billion, with licensing revenue estimated between $1.285 billion and $1.335 billion [8]. - Gross margins are anticipated to be approximately 88% on a GAAP basis and 90% on a non-GAAP basis [8].

Accessibility StatementSkip Navigation WILMINGTON, Del., Nov. 18, 2025 /PRNewswire/ --Â DuPont (NYSE: DD) announced today the early results of its previously announced tender offer (the "Tender Offer") to purchase for cash up to $739,256,000 aggregate principal amount (the "Maximum Tender Amount") of its 5.419% Notes due 2048 issued on November 28, 2018 (the "2048 Notes"). The Tender Offer is being made pursuant to the terms and conditions set forth in the Offer to Purchase, dated November 3, 2025 (the "Off ...

Accessibility StatementSkip Navigation DALLAS, Nov. 18, 2025 /PRNewswire/ -- Jacobs (NYSE: J) today announced the appointment of Diane Bryant to its Board of Directors, effective immediately. Bryant is a distinguished technology executive with more than three decades of leadership experience spanning the global semiconductor industry, cloud computing services, artificial intelligence applications and technology-based healthcare solutions. Bryant is widely recognized as a transformative leader in technology ...

Accessibility StatementSkip Navigation SYDNEY, Nov. 18, 2025 /PRNewswire/ -- Kazia Therapeutics Limited (Nasdaq: KZIA), an oncology-focused drug development company, today announced that a patient with stage IV triple-negative breast cancer (TNBC) treated under an FDA-authorized single-patient expanded access protocol combining paxalisib with pembrolizumab (Keytruda®) and standard chemotherapy has achieved an initial immune-complete response (iCR) per iRECIST criteria. This outcome suggests a profound radio ...